Privately held since it was established in Los Angeles in 2003, the company employs around 35 people, 30 of them molecular biologists, cell biologists, biochemists and pathologists holding 15 PhDs, 5 MDs and 15 master's degrees. The biorepository holds over 450,000 individual biomaterials spanning oncology, dermatology, neurology, immunology, infectious disease, and autoimmune and metabolic disorders, sourced through a network of academic and professional clinical institutions. Formats include fresh frozen and OCT-embedded tissue, formalin-fixed paraffin-embedded blocks, an FDA tissue panel, whole blood, serum and plasma, bone marrow and peripheral blood mononuclear cells, extracted RNA and DNA, and fluids such as urine, stool, ascites, saliva, sputum, synovial fluid and cerebrospinal fluid. Custom tissue-based research, including single-cell suspensions prepared to order from human tissue, is the fastest growing part of the business.
ProteoGenex, Inc.
ProteoGenex is a leading provider of ethically obtained, high-quality human biospecimens, clinical tissue microarrays, and associated clinical data to the global biomedical research community. Specializing in highly annotated oncology samples, viable biofluids, and longitudinal collections, ProteoGenex accelerates biomarker validation, target discovery, and molecular diagnostics development.
